Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Multi drug-resistant and mycobacterial infections are a major public health challenge, leading to high mortality and socio economic burdens through worldwide. Novel therapeutics are necessary to treat the drug resistant strains, since no new chemical entities are emerged in the last four decades for the treatment of TB. | Novel drug targets for Mycobacterium tuberculosis 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis